PLAY PODCASTS
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
Episode 230

Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?

Older age is more a state of mind than a biological definition. We should be proactive in monitoring and treating all patients with chronic hepatitis B, regardless of age. Listen as Dr George Lau discusses these and other issues in HBV management.

Decera Clinical Education Infectious Disease Podcast · George Lau MBBS HKU MD HKU FRCP Edin Lond FAASLD USA

December 15, 202212m 38s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?

Listen as Dr George Lau discusses these questions and more for strategizing the monitoring and treatment of older adults with HBV. 

Presenter: 
George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA)
Chairman
Humanity and Health Medical Group
Hong Kong, China
Chair, Professor, and Co-Director
Liver Diseases & Transplant Centre
The Fifth Medical Centre of Chinese PLA General Hospital
Beijing, China

Link to full program:
https://bit.ly/3fg9fwB


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

treatmentantiviralsviral hepatitisaltentecavirviral suppressionfibroscanliver fibrosishbv infectionriskhepatocellular carcinomanucleotide analoguesalanine aminotransferasehbv dnahepatitis bliver enzymesolder adultliver canceroldermonitoringrisk reductionfibrosisolder agehbvliver malignancynucleoside analogueshcchepatitis b virus